Skip to main content

LCD L33576: Urodynamics

LCD L33576, Urodynamics, is the Local Coverage Determination that Wellpoint Federal applies to claims from 10 states (CT, IL, MA, ME, MN, NH, NY, RI and others), effective 2026-04-01 and first in force 2015-10-01. The policy text runs 693 words, and its billing and coding article A57455 lists 520 ICD-10-CM codes that support medical necessity for 10 procedure codes. 1 other contractor version share this title, so the criteria depend on where the service is furnished. Counting every linked billing and coding article, this one lists 520 covered ICD-10-CM codes: 175 more codes than L34056 (CGS Administrators, LLC, 345 codes, revised 2026-10-08).

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
Wellpoint Federal
States and territories
10
CT IL MA ME MN NH NY RI VT WI
Revision effective
2026-04-01
Original effective
2015-10-01
Policy text
693 words
Covered ICD-10 codes (articles)
520

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L33576
ContractContractorTypeStates
06101Wellpoint FederalMAC - Part AIL
06201Wellpoint FederalMAC - Part AMN
06301Wellpoint FederalMAC - Part AWI
06102Wellpoint FederalMAC - Part BIL
06202Wellpoint FederalMAC - Part BMN
06302Wellpoint FederalMAC - Part BWI
13101Wellpoint FederalA and B and HHH MACCT
13201Wellpoint FederalA and B and HHH MACNY
13102Wellpoint FederalA and B and HHH MACCT
13202Wellpoint FederalA and B and HHH MACNY
13282Wellpoint FederalA and B and HHH MACNY
13292Wellpoint FederalA and B and HHH MACNY
14411Wellpoint FederalA and B and HHH MACRI
14211Wellpoint FederalA and B and HHH MACMA
14311Wellpoint FederalA and B and HHH MACNH
14511Wellpoint FederalA and B and HHH MACVT
14111Wellpoint FederalA and B and HHH MACME
14112Wellpoint FederalA and B and HHH MACME
14212Wellpoint FederalA and B and HHH MACMA
14312Wellpoint FederalA and B and HHH MACNH
14512Wellpoint FederalA and B and HHH MACVT
14412Wellpoint FederalA and B and HHH MACRI

Billing and coding article A57455: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A57455 (Billing and Coding: Urodynamics) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A57455: Billing and Coding: Urodynamics (Billing and Coding, effective 2026-04-01)

Covered ICD-10-CM codes
520
1 group
Non-covered ICD-10-CM codes
0
Procedure codes listed
10
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A57455
ICD-10-CMDescription (FY2027)
A18.13Tuberculosis of other urinary organs
A52.10Symptomatic neurosyphilis, unspecified
A52.11Tabes dorsalis
A52.12Other cerebrospinal syphilis
A52.13Late syphilitic meningitis
A52.14Late syphilitic encephalitis
A52.15Late syphilitic neuropathy
A52.16Charcot's arthropathy (tabetic)
A52.17General paresis
A52.19Other symptomatic neurosyphilis
A52.3Neurosyphilis, unspecified
A80.9Acute poliomyelitis, unspecified
C61Malignant neoplasm of prostate
C70.1Malignant neoplasm of spinal meninges
C72.0Malignant neoplasm of spinal cord
C72.1Malignant neoplasm of cauda equina
C79.82Secondary malignant neoplasm of genital organs
D29.1Benign neoplasm of prostate
D33.4Benign neoplasm of spinal cord
D40.0Neoplasm of uncertain behavior of prostate
D49.4Neoplasm of unspecified behavior of bladder
D49.511Neoplasm of unspecified behavior of right kidney
D49.512Neoplasm of unspecified behavior of left kidney
D49.519Neoplasm of unspecified behavior of unspecified kidney

Procedure codes: 51725, 51726, 51727, 51728, 51729, 51736, 51741, 51792, 51797, 55899.

Coverage indications, limitations and medical necessity

Abstract:

Urodynamic studies have become an increasingly important part of the evaluation of voiding dysfunction. Cystometrogram, uroflowmetry, urethral pressure profile, sphincter electromyogram, stimulus-evoked response, and voiding pressure studies are used to identify abnormal voiding patterns in symptomatic patients with disorders of urinary flow. Each of the urodynamic studies has benefits and limitations that must be respected for each specific clinical application.

Cystometrogram, simple/complex

is used to evaluate detrusor contractions and abnormalities of bladder compliance, to measure post-voiding residual, to determine bladder capacity and to detect DSD (detrusor sphincter dyssynergia). Normal results are expected in stress incontinence.

Complex cystometrogram involves the use of calibrated electronic equipment to measure intra-abdominal, total bladder, and true detrusor pressures simultaneously. Its purpose is to differentiate an involuntary detrusor contraction or reversed bladder compliance from an increase in intra-abdominal pressure. False positives may be a problem, especially in the elderly.

Uroflowmetry, simple/complex

measures the urine flow rate visually, electronically or with the use of a disposable unit. The flow rate reflects the combined activity of the detrusor muscle, bladder neck, and urethral function. Decreased flow rate may be due to poor detrusor function from, for example, neurologic lesions, obstructing BPH, or cystocele. Increased flow rate may indicate poor urethral function causing, for example, stress urinary incontinence (SUI) or intrinsic sphincter dysfunction (ISD).

Urethral pressure profile studies

measure resting and dynamic pressures along the length of the urethra responsible for maintaining continence. This test has limited applications, e.g. artificial urinary sphincter. Urethral pressure studies should be reserved for those patients in whom other tests are inconclusive. The test is performed to rule out severe urethral incompetence.

Stimulus Evoked Response

has a limited application in practical urology but can be used to evaluate cases of suspected cauda equina syndrome.

Voiding Pressure Studies (VP)

can measure detrusor contractility and detect outlet pressure obstruction if the patient is able to void. Simultaneous measurement of detrusor and urethral pressures during voiding is especially helpful in diagnosing urodynamic obstruction.

Intra-abdominal Voiding Pressure (AP)

can contribute to the evaluation of true detrusor muscle function by accounting for any component of intra-abdominal pressure in the bladder pressure voiding curve.

Indications:

Urodynamic studies are indicated only after an initial evaluation is performed that at minimum includes an appropriate history, physical exam, and urinalysis with microscopy. Infection, if present, should be treated and effectiveness of treatment observed before further diagnostic (urodynamic) testing or other therapeutic interventions are undertaken.

Urodynamic testing is covered under Medicare when medically necessary to assist in the diagnosis of urologic dysfunction and when any of the following apply:

• Uncertain diagnosis and inability to develop an appropriate treatment plan based on the basic diagnostic evaluation above.

• Failure to respond to an adequate therapeutic trial.

• Consideration of urologic surgical intervention, particularly if previous surgery failed or if the patient is a high surgical risk.

• Presence of other comorbid conditions such as incontinence associated with recurrent symptomatic urinary tract infection, persistent symptoms of difficult bladder emptying, history of previous anti-incontinence surgery or radical pelvic surgery, beyond hymen and symptomatic pelvic prolapse, prostate nodule, asymmetry or other suspicion of prostate cancer, abnormal post-void-residual urinalysis, and neurologic conditions affecting voiding function such as multiple sclerosis and spinal cord lesions or injury.

Manometric studies may be medically necessary when performed for reconstruction of the ureter or obstruction of the ureter.

Limitations:

• Testing must be restricted to only those urodynamic testing procedures which are necessary to differentiate the etiology of the voiding dysfunction and must not consist of an entire battery of tests applied routinely to all patients.

• Payment for these procedures is predicated on the presence of signs and symptoms of voiding dysfunction that must be clearly documented in the medical record.

• The tests performed must be appropriate to analyze the patient's signs and symptoms or to guide further medical and/or surgical decision-making.

• The use of any of these procedures in a screening capacity does not represent a payable service.

• Pelvic descensus syndromes without urinary symptoms do not qualify for urodynamic testing.

Urinary flow rates determined by the patient at home and recorded for physician evaluation are not eligible for Medicare reimbursement.

Summary of evidence (opening)

N/A

the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2026-04-01
Last reviewed by the contractor
2017-09-29
MCD version
24
Derived from
L26851

The contractor lists one National Coverage Determination as related: NCD 230.2 Uroflowmetric Evaluations. Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Wellpoint Federal hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L33576 cover?

Urodynamic studies have become an increasingly important part of the evaluation of voiding dysfunction. Cystometrogram, uroflowmetry, urethral pressure profile, sphincter electromyogram, stimulus-evoked response, and voiding pressure studies are used to identify abnormal voiding patterns in symptomatic patients with disorders of urinary flow. Each of the urodynamic studies has benefits and limitations that must be… The full 693-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L33576 apply to?

Wellpoint Federal applies it to Medicare claims in 10 states: CT, IL, MA, ME, MN, NH, NY, RI, VT, WI. It binds only that contractor; 1 other contractor version of this title governs other jurisdictions, and elsewhere the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L33576?

The companion billing and coding article A57455 lists 520 ICD-10-CM codes in 1 group that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L33576?

A denial under LCD L33576 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A57455's 520 covered diagnosis codes, then file a redetermination with Wellpoint Federal within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.